24/10/2014 21:31:36 Free Membership Login

Mylan News (NASDAQ:MYL)

DateTimeSource
Headline
10/06/20147:30AMPRNUSMylan Launches Generic Combivir®
Mylan Launches Generic Combivir® - Product strengthens growing antiretroviral franchise in the U.S. - PR Newswire PITTSBURGH, Oct. 3, 2014 PITTSBURGH, Oct. 3, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced the U.S. launch of its Lamivudine and Zidovudine Tablets USP, 150 mg/300 mg, which is the generic... More...>>
10/03/20146:37PMDJNMARKET SNAPSHOT: U.S. Stocks Rally On Strong Jobs Report
By Anora Mahmudova and Sara Sjolin, MarketWatch NEW YORK (MarketWatch)--The S&P 500 enjoyed its biggest one-day gain in nearly two months, while the Dow Jones Industrial Average tallied its biggest gain in seven months, thanks in large part to a stronger-than-expected jobs report that delivered a dose of confidence... More...>>
10/03/20146:27PMDJNMARKET SNAPSHOT: U.S. Stocks Rally After Upbeat Jobs Report
By Anora Mahmudova and Sara Sjolin, MarketWatch NEW YORK (MarketWatch)--U.S. stock prices rallied on Friday bolstered by stronger-than-expected jobs report that suggested the economy is on a solid footing. The jobs report was not only robust, it was also what markets craved--strong headline numbers along with a dose of... More...>>
10/03/20146:18PMDJNMARKET SNAPSHOT: U.S. Stocks Rise After Strong Jobs Report
By Anora Mahmudova and Sara Sjolin, MarketWatch NEW YORK (MarketWatch) -- U.S. stock prices drew positive momentum from a strong jobs report that suggests that the U.S. economy is stronger than expectations. The S&P 500 (SPX) rose 9 points, or 0.5%, to 1,955.09, with healthcare and financial stocks leading the gains... More...>>
10/03/20145:43PMDJNU.S. Hot Stocks: Hot Stocks to Watch
Among the companies with shares expected to actively trade in Friday's session are General Motors Co. (GM), J.P. Morgan Chase & Co. (JPM) and Mylan Inc. (MYL). General Motors announced two new recalls Friday covering almost 524,400 cars in North America, suggesting the auto maker is still struggling to meet new quality... More...>>
10/03/20147:00AMPRNUSMylan Increases Third Quarter and Full Year 2014 Adjusted Diluted EPS Guidance Range
Mylan Increases Third Quarter and Full Year 2014 Adjusted Diluted EPS Guidance Range -Third Quarter 2014 Financial Results Conference Call to be Held on Oct. 30, 2014- PR Newswire PITTSBURGH, Oct. 3, 2014 PITTSBURGH, Oct. 3, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that it expects third quarter adjusted... More...>>
09/23/20146:01PMDJNStocks Fall For U.S. Firms in Pending Inversion Deals After Treasury Move -- Update
By Saumya Vaishampayan Shares of U.S. companies that have bid for foreign companies through so-called inversions came under pressure on Tuesday, after the Obama administration updated rules that sapped some of the tax benefits from these moves. Medtronic Inc. fell 2.7%, among the top decliners on the S&P 500. The company... More...>>
09/23/20146:01PMDJNStocks Fall For U.S. Firms in Pending Inversion Deals
Shares of U.S. companies that have bid for foreign companies through so-called inversions came under pressure on Tuesday, after the Obama administration updated rules that sapped some of the tax benefits from these moves. Medtronic Inc. fell 2.7%, among the top decliners on the S&P 500. The company has agreed to acquire... More...>>
09/23/20146:00PMDJNStocks Fall For U.S. Firms in Pending Inversion Deals After Treasury Move
By Saumya Vaishampayan Shares of U.S. companies that have bid for foreign companies through so-called inversions came under pressure on Tuesday, after the Obama administration updated rules that sapped some of the tax benefits from these moves. Medtronic Inc. fell 2.7%, among the top decliners on the S&P 500. The company... More...>>
09/16/20147:30AMPRNUSMylan Commences Phase III Clinical Trials for its Generic Version of Advair Diskus® and Insulin Analog to Lantus®
Mylan Commences Phase III Clinical Trials for its Generic Version of Advair Diskus® and Insulin Analog to Lantus® Clinical Trials Mark Important Milestone in Development of Two Highly Complex Products PR Newswire PITTSBURGH, Sept. 16, 2014 PITTSBURGH, Sept. 16, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL), one of the... More...>>
09/16/201412:13AMDJNU.S. Hot Stocks: Hot Stocks to Watch
Among the companies with shares expected to actively trade in Monday's session are Cognizant Techology Solutions Corp. (CTSH), RadioShack Corp. (RSH) and Microsoft Corp. (MSFT). Cognizant said Monday it agreed to buy closely held TriZetto Corp. for $2.7 billion in cash, as it looks to capitalize on shifts in health-care... More...>>
09/15/20146:30AMPRNUSMylan Signs Agreement with Gilead to Accelerate Access to Hepatitis C Treatments, Sovaldi® (Sofosbuvir) and Single Tablet Re...
Mylan Signs Agreement with Gilead to Accelerate Access to Hepatitis C Treatments, Sovaldi® (Sofosbuvir) and Single Tablet Regimen of Ledipasvir/Sofosbuvir, in Developing Countries PR Newswire PITTSBURGH and HYDERABAD, India, Sept. 15, 2014 PITTSBURGH and HYDERABAD, India, Sept. 15, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq:... More...>>
09/10/20147:00AMPRNUSMylan to Acquire U.S. Rights to Arixtra® (fondaparinux sodium) Injection from Aspen
Mylan to Acquire U.S. Rights to Arixtra® (fondaparinux sodium) Injection from Aspen Provides Another Important and Highly Complex Injectable to Complement Mylan Institutional's Growing Portfolio in the U.S. PR Newswire PITTSBURGH, Sept. 10, 2014 PITTSBURGH, Sept. 10, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today... More...>>
09/08/20147:00AMPRNUSCourt Grants Summary Judgment in Favor of Mylan and FDA Related to Generic Precedex™
Court Grants Summary Judgment in Favor of Mylan and FDA Related to Generic Precedex™ Mylan Free to Immediately Resume Distribution of Its Generic Precedex Product PR Newswire PITTSBURGH, Sept. 8, 2014 PITTSBURGH, Sept. 8, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today commented on a ruling by the U.S. District... More...>>
09/05/20147:30AMPRNUSMylan Launches Generic Boniva® Injection
Mylan Launches Generic Boniva® Injection PR Newswire PITTSBURGH, Sept. 5, 2014 PITTSBURGH, Sept. 5, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that it has launched Ibandronate Sodium Injection, 1 mg (base)/mL, packaged in 3 mg (base)/3 mL pre-filled glass syringes, which is the generic version of Hoffmann-La... More...>>
08/28/201411:21AMPRNUSMylan's ANDA for Three Times Per Week Generic Copaxone® 40 mg/mL Accepted for Filing by FDA
Mylan's ANDA for Three Times Per Week Generic Copaxone® 40 mg/mL Accepted for Filing by FDA PR Newswire PITTSBURGH, Aug. 28, 2014 PITTSBURGH, Aug. 28, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its abbreviated new drug application (ANDA) for a three times per week Glatiramer Acetate Injection... More...>>
08/25/20148:01AMPRNUSReady2Go™ Draft Winners Join Pro Football MVP Adrian Peterson in Educational Video About Anaphylaxis Preparedness
Ready2Go™ Draft Winners Join Pro Football MVP Adrian Peterson in Educational Video About Anaphylaxis Preparedness Video Will Aim to Address Gaps in Knowledge About Life-Threatening (Severe) Allergies PR Newswire PITTSBURGH, Aug. 25, 2014 PITTSBURGH, Aug. 25, 2014 /PRNewswire/ -- Mylan Specialty, the fully integrated... More...>>
08/22/20147:30AMPRNUSMylan Launches First Generic Klor-Con® Extended-Release Tablets
Mylan Launches First Generic Klor-Con® Extended-Release Tablets PR Newswire PITTSBURGH, Aug. 22, 2014 PITTSBURGH, Aug. 22, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that it has launched Potassium Chloride Extended-release Tablets USP, 8 mEq (600 mg) and 10 mEq (750 mg), which is the generic version... More...>>
08/19/201411:42AMPRNUSMylan Launches Generic Precedex™ Injection - Another Key Product Approval
Mylan Launches Generic Precedex™ Injection - Another Key Product Approval PR Newswire PITTSBURGH, Aug. 19, 2014 PITTSBURGH, Aug. 19, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) announced that its business Mylan Institutional has launched Dexmedetomidine Hydrochloride Injection, 100 mcg (base)/mL, packaged in 200 mcg... More...>>
08/11/20147:30AMPRNUSMylan Launches Generic Xeloda® Tablets
Mylan Launches Generic Xeloda® Tablets PR Newswire PITTSBURGH, Aug. 11, 2014 PITTSBURGH, Aug. 11, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that it has launched Capecitabine Tablets USP, 150 mg and 500 mg, the generic version of Genentech's Xeloda® Tablets. Mylan received final approval from the U.S... More...>>


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us nasdaq myl141024 21:31